PHAXIAM Therapeutics: Extension of the Observation Period of the Receivership Procedure
LYON, France--(BUSINESS WIRE)--Regulatory News:
PHAXIAM Therapeutics (Euronext: PHXM - FR001400K4B1), a biopharmaceutical company ("the Company" or "PHAXIAM") developing innovative treatments for severe and resistant bacterial infections, announces the continuation of its observation period under the receivership procedure.
The Commercial Court of Lyon decided on April 30, 2025 to extend the observation period and set the bid review hearing on May 21, 2025.
This extension of the observation period will enable potential buyers to improve their offers.
As a reminder, whether or not a bid is accepted, the Commercial Court of Lyon will in any case soon pronounce the judicial liquidation of the Company. In this context, the Company will request the delisting of PHAXIAM shares from Euronext.
About PHAXIAM Therapeutics
PHAXIAM is a biopharmaceutical company developing innovative treatments for resistant bacterial infections, which are responsible for many serious infections. The company is building on an innovative approach based on the use of phages, natural bacteria-killing viruses. PHAXIAM is developing a portfolio of phages targeting 3 of the most resistant and dangerous bacteria, which together account for more than two-thirds of resistant hospital-acquired infections: Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa.
PHAXIAM is listed on the Euronext regulated market in Paris (ISIN code: FR001400K4B1, ticker: PHXM). PHAXIAM is part of the CAC Healthcare, CAC Pharma & Bio, CAC Mid & Small, CAC All Tradable, EnterNext PEA-PME 150 and Next Biotech indexes.
For more information, please visit www.phaxiam.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
AI Governance Market to Reach USD 36 Billion by 2034, Growing at a 12% CAGR
AI Governance Market Overview 2025-2034 Luton, Bedfordshire, United Kingdom, June 06, 2025 (GLOBE NEWSWIRE) -- As of 2024, the global AI Governance Market stands at a valuation of around $12 billion, fueled by heightened awareness of data ethics, mounting regulatory requirements, and an urgent demand for robust compliance frameworks. This fast-evolving sector is gaining strategic importance across industries, driven by both public and private sector interest in ensuring that artificial intelligence (AI) technologies are developed and deployed responsibly. By 2034, the market is forecast to expand significantly, reaching an estimated $36 billion, reflecting a Compound Annual Growth Rate (CAGR) of approximately 12% over the forecast period. Download PDF Brochure: The growth of this market is being catalyzed by technological progress in AI—especially in machine learning (ML) and natural language processing (NLP)—as well as a growing global consensus that ethical considerations and transparency must be embedded in AI systems. AI governance has transitioned from a niche compliance topic to a central aspect of corporate digital transformation strategies. Market Segmentation and Performance By Product Type The market is segmented into Software, Services, and Hardware. Among these, software solutions dominate the market share, primarily due to their widespread application across compliance, analytics, and risk mitigation functions. These tools allow organizations to monitor AI outputs, ensure regulatory adherence, and manage internal governance policies. Services, particularly those involving audits, consultancy, and system integration, are seeing growing adoption as enterprises seek tailored solutions. Meanwhile, the hardware segment, though currently smaller, is gaining momentum thanks to increased demand for edge computing and the need for secure, localized AI processing infrastructure. By Application Key application areas include Risk Management, Data Privacy, Compliance, Cybersecurity, and Analytics. Among these, data analytics takes the lead, as companies handle vast amounts of unstructured and structured data requiring transparent and ethical handling. The growing complexity of AI applications in financial services, healthcare, and government further boosts demand for governance tools that safeguard sensitive information and prevent misuse. Cybersecurity applications are witnessing a surge, driven by rising threats and a regulatory environment that mandates secure AI deployment. AI systems that make autonomous decisions must be governed to prevent unintended consequences, bias, or exploitation, underscoring the critical role of governance in safeguarding system integrity. By End User Enterprises, Governments, and Small & Medium Enterprises (SMEs) represent the core user base. Large enterprises, with greater resources, currently account for a substantial market share as they lead the way in AI adoption. However, SMEs are increasingly investing in scalable and cost-efficient AI governance solutions to enhance competitiveness and ensure compliance with emerging regulations. Governments, too, are emerging as significant consumers of AI governance technologies. National agencies are implementing AI in public services and are setting examples through ethical standards and regulation-driven deployments. By Deployment & Technology The cloud-based deployment model holds a commanding market share due to its scalability and efficiency. However, hybrid deployments are gaining popularity as organizations seek the security of on-premises models with the flexibility of the cloud. Technologies underpinning governance solutions include Machine Learning, Natural Language Processing (NLP), and Predictive Analytics, all of which enable better control, automation, and explainability of AI models. Browse full Report - Market SegmentationProduct Type - Hardware - Software - ServicesApplication - Application Development - System Integration - Data Analytics - CybersecurityEnd-User Industry - Information Technology - Healthcare - Manufacturing - Retail - Education - FinanceOrganization Size - Small Enterprises - Medium Enterprises - Large EnterprisesDeployment Type - On-Premises - Cloud-Based - HybridGeographic Region - North America - Latin America - Europe - Asia-Pacific - Middle East and Africa Regional Insights Geographically, North America dominates the global AI governance market, with approximately 40% market share in 2024. This is due to the region's technological maturity, strong regulatory frameworks, and concentration of major players such as Microsoft, IBM, and Google. Government support for ethical AI initiatives also drives regional growth. Europe follows with a projected 25% share, supported by GDPR-style privacy regulations and proactive legislative efforts to define ethical AI standards. However, economic disparity between countries within the EU may create uneven growth. The Asia-Pacific region represents a high-growth area, projected to register a CAGR of 8% through 2034. Rapid digitization, government-led innovation programs in countries like China and India, and a young, tech-savvy population contribute to rising demand for governance tools. Despite infrastructural limitations in certain regions, Asia-Pacific is poised to emerge as a major player. Emerging markets like Latin America and the Middle East & Africa (MEA) also present promising growth opportunities, with projected CAGRs of 7% and 9%, respectively. Increased investment in smart infrastructure and AI research, particularly in the Gulf nations, adds to the growth momentum, although regulatory and political hurdles may hamper progress. Market Drivers Several key factors are propelling the AI governance market forward. First and foremost is the rising regulatory pressure globally, with governments working to establish clear frameworks to guide ethical AI deployment. From the European Union's AI Act to regulatory proposals in the United States and Asia, compliance is no longer optional but a necessity. Additionally, technological advancement in AI systems necessitates more sophisticated governance frameworks. As organizations rely on AI for mission-critical tasks, the need to manage risks, explain AI decisions, and ensure accountability becomes paramount. The ongoing digital transformation across industries—from healthcare to finance—also contributes significantly. Organizations are embedding AI into their core operations and simultaneously adopting governance tools to address ethical concerns and reduce liability. Buy Now : Challenges and Restraints Despite rapid growth, the AI governance market faces several challenges. One of the most pressing is the shortage of skilled professionals specializing in AI ethics, legal compliance, and regulatory technology. This talent gap can slow implementation and hinder the adoption of comprehensive governance strategies. Another critical restraint is the lag between technological innovation and regulatory responses. AI capabilities are evolving so rapidly that many governance frameworks quickly become outdated, forcing businesses into a reactive posture. Operational and supply chain constraints, including delays in AI model auditing tools and consulting services, can impede rollout. Moreover, businesses navigating multiple jurisdictions must deal with fragmented and often contradictory legal requirements, increasing compliance complexity and operational costs. Emerging Opportunities and Trends Amid these challenges, new opportunities are emerging. The rise in consumer awareness about data privacy is encouraging organizations to invest in transparent AI practices, creating demand for user-friendly governance tools. Companies that demonstrate ethical responsibility are gaining a competitive edge and building brand trust. Collaborative governance models are also on the rise, with businesses forming partnerships to share best practices, tools, and expertise. This trend is particularly relevant in sectors like healthcare and finance, where compliance requirements are stringent. Moreover, AI governance is transitioning from a reactive to a proactive strategy. Businesses are embedding governance into their product development cycles, ensuring models are auditable and explainable from the outset. As AI becomes ubiquitous, the governance market is evolving into an essential pillar of digital infrastructure. Key Competitors Microsoft Google IBM Amazon Web Services (AWS) Oracle Salesforce SAP Accenture Palantir Technologies Infosys Wipro TCS (Tata Consultancy Services) NTT DATA Deloitte McKinsey & Company Recent Developments and Strategic Moves Microsoft In October 2023, Microsoft expanded its internal AI governance framework to enhance ethical oversight across its product lines. This proactive move highlights the company's commitment to responsible AI and may influence industry-wide best practices. Google In September 2023, Google released an upgraded AI ethics toolkit that enables organizations to audit AI systems for compliance and fairness. This innovation underscores the importance of transparency in AI deployment and aligns with growing global regulatory expectations. IBM In August 2023, IBM partnered with the Indian government to co-develop AI governance frameworks. This collaboration marks a strategic move in shaping national AI policies and positions IBM as a thought leader in emerging markets. TCS (Tata Consultancy Services) In July 2023, TCS acquired a European AI ethics consultancy, strengthening its position as a global provider of ethical AI solutions. This acquisition reflects the growing demand for specialized expertise in governance. Accenture In June 2023, Accenture received regulatory approval for its AI governance framework, a move that is expected to set industry standards. The framework is designed to help organizations align AI applications with international laws, further establishing Accenture as a leader in ethical AI deployment. This report is also available in the following languages : Japanese (AIガバナンス市場), Korean (AI 거버넌스 시장), Chinese (人工智能治理市场), French (Marché de la gouvernance de l'IA), German (Markt für KI-Governance), and Italian (Mercato della governance dell'IA), etc. Request Sample Pages: More Research Finding – Cloud Infrastructure Entitlement Management CIEM Market The Cloud Infrastructure Entitlement Management (CIEM) market is poised for substantial growth, with an anticipated market value of approximately $2 billion in 2024. Projections suggest that the market will expand to around $6 billion by 2034. Cloud-Based Information Governance Market The cloud-based information governance market is valued at approximately $10 billion in 2024, driven by the increasing need for data compliance and security across industries. This market is projected to grow significantly, reaching an estimated value of $24 billion by 2034. The forecasted Compound Annual Growth Rate (CAGR) for the period from 2025 to 2034 is approximately 9.2%. MLOps Market The global MLOps (Machine Learning Operations) market is poised for substantial growth, currently valued at approximately $6.8 billion in 2024. Projections indicate a robust increase, with an anticipated market value reaching around $23 billion by 2034. This growth trajectory represents a Compound Annual Growth Rate (CAGR) of approximately 13.5% during the forecast period from 2025 to 2034. Data Management Platforms Market The global data management platforms (DMP) market is valued at approximately $5.4 billion, driven by the increasing demand for data-driven decision-making and advanced analytics across industries. The market is poised for robust growth, projected to reach around $12.4 billion by 2034, reflecting a compound annual growth rate (CAGR) of 8.7% during the forecast period from 2025 to 2034. Identity and Access Management IAM Software Market The global Identity and Access Management (IAM) software market is valued at approximately $15.5 billion, reflecting a robust demand driven by an increasing focus on cybersecurity, regulatory compliance, and the need for streamlined user access across burgeoning digital environments. The market is projected to grow significantly, reaching an estimated value of $34.7 billion by 2034. This growth translates to a compelling Compound Annual Growth Rate (CAGR) of 8.5% during the forecast period from 2025 to 2034. Data Privacy Management Platform Market The global data privacy management platform market is valued at approximately $3 billion, reflecting increased regulatory scrutiny and consumer demand for enhanced data protection solutions. The market is projected to reach $7 billion by 2034, driven by the growth of digital transformation initiatives and the rising significance of compliance with data privacy regulations, such as GDPR and CCPA. Healthcare Information Governance Solution Igs Market The global Healthcare Information Governance Solutions market is valued at approximately $2.3 billion in 2024, with robust growth anticipated over the next decade. By 2034, the market is projected to reach around $5.7 billion, reflecting significant investment in healthcare data management and compliance. This represents a Compound Annual Growth Rate (CAGR) of 9.3% during the forecast period from 2025 to 2034. U.S. Healthcare Information Governance Solution Igs Market The United States healthcare information governance solutions market is valued at approximately $5.2 billion. The sector is poised for significant expansion, with projections estimating a market value of around $9.3 billion by 2034, driven by a growing emphasis on data integrity and regulatory compliance. This results in a compound annual growth rate (CAGR) of about 6.1% during the forecast period from 2025 to 2034. Exploring Enterprise Governance Risk Compliance Market The global Enterprise Governance, Risk, and Compliance (EGRC) market is valued at approximately $17 billion in 2024, with projections indicating a growth trajectory that could see it reach around $35 billion by 2034. This growth translates to a Compound Annual Growth Rate (CAGR) of about 7.5% during the forecast period of 2025–2034. Data Fabric Market The global data fabric market was valued at approximately USD 2.5 billion. Projections indicate significant growth, with the market expected to reach around USD 13 billion by 2034. This represents a compound annual growth rate (CAGR) of about 18% over the forecast period. Data Discovery Market The global data discovery market is experiencing robust growth, driven by the increasing need for organizations to analyze vast amounts of structured and unstructured data. In 2024, the market is valued at approximately USD 16.24 billion. Patient Safety and Risk Management Software Market The global patient safety and risk management software market size is expected to reach above USD 5.88 billion by 2034 from a USD 2.08 billion in 2024 at more than 9.10% CAGR from 2025 to 2034. Cloud IAM Market The cloud IAM market is expected to grow at 17.70 % CAGR from 2020 to 2029. It is expected to reach above USD 13.87 Billion by 2029 from USD 3.20 Billion in 2020. Finance cloud Market The finance cloud Market is expected to grow at 20.75% CAGR from 2022 to 2029. It is expected to reach above USD 110.1 Billion by 2029 from USD 20.10 Billion in 2020. Cybersecurity Market The global Cybersecurity Market is expected to grow at 10.6 % CAGR from 2020 to 2029. It is expected to reach above USD 850.17 billion by 2029 from USD 159.65 billion in 2020. Cloud Security Market The Cloud Security Market Is Expected To Grow At 17 % CAGR From 2022 To 2029. It Is Expected To Reach Above USD 87.82 Billion By 2029 From USD 21.69 Billion In 2020. CONTACT: Irfan Tamboli (Head of Sales) Phone: + 1704 266 3234 Email: sales@ while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
2 days ago
- Yahoo
HighCo : Shareholding
INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES Declaration pursuant to Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulations of the Autorité des marchés financiers (AMF) Date of settlementof information Total number of shares Number of shares without voting rights (*) Number of voting rights for threshold calculation (**) Number of actual voting rights (exercisable at shareholders' meeting) May 31, 2025 20 455 403 806 842 22 284 457 21 477 615 April 30, 2025 20 455 403 810 840 22 284 457 21 473 617 March 31, 2025 20 455 403 809 380 22 282 875 21 473 495 February 28, 2025 20 455 403 812 886 22 282 791 21 469 905 January 31, 2025 20 455 403 818 981 22 282 977 21 463 996 December 31, 2024 20 455 403 817 845 22 282 774 21 464 929 (*) exclusively consisting of treasury shares.(**) theoretical voting rights to calculate the threshold crossing including the voting right of treasury shares (article 223-11 of the General Regulations AMF). Cécile COLLINA-HUE Nicolas CASSARManaging Director Press Relations+33 1 77 75 65 06 +33 4 88 71 35 46comfi@ take place after market close. Quarterly Gross ProfitQ2 and H1 2025 Gross Profit: Tuesday, 22 July 2025Q3 and 9-months 2025 Gross Profit: Wednesday, 15 October 20252025 Gross Profit: Wednesday, 28 January 2026 Analyst Meeting (French Society of Financial Analysts – SFAF)2025 Half-year Earnings conference call at 10:00 a.m.: Thursday, 11 September 2025 Earnings2025 Half-year Earnings: Wednesday, 10 September 2025 HighCo is a component stock of the indices CAC® Small (CACS), CAC® Mid&Small (CACMS) and CAC® All-Tradable (CACT), Euronext® Tech Croissance (FRTPR) and Enternext® PEA-PME 150 index (ENPME). ISIN: FR0000054231 Reuters: Bloomberg: HCO FP For further financial information and press releases, go to This English translation is for the convenience of English-speaking readers. Consequently, the translation may not be relied upon to sustain any legal claim, nor should it be used as the basis of any legal opinion. HighCo expressly disclaims liability for any inaccuracy herein. Attachment Shareholding as 31_05_2025Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Yahoo
Nicox: Notice of the Ordinary and Extraordinary Shareholders' Meeting on June 27, 2025 and appointment of an ad hoc representative
Press Release Nicox: Notice of the Ordinary and Extraordinary Shareholders' Meeting on June 27, 2025 and appointment of an ad hoc representative June 6, 2025 – release at 7:30 am CET Sophia Antipolis, FranceNicox SA (Euronext Growth Paris: FR0013018124, ALCOX), an international ophthalmology company, reminds its shareholders that the Ordinary and Extraordinary General Meeting will be held on Friday, June 27, 2025 at 2:30 p.m., at the Company's headquarters located at Sundesk Sophia Antipolis, rue Evariste Galois, Emerald Square, Bâtiment C – 06410 agenda and the text of the draft resolutions proposed to the Ordinary and Extraordinary Shareholders' Meeting are included in the notice of meeting published in the Bulletin des Annonces Légales Obligatoires (Official Bulletin of Mandatory Legal Announcements) No. 61 dated May 21, 2025 (No. 2502198) and No. 64 dated May 28, 2025 ( No. 2501651).Appointment of an A Representative to Represent Defaulting ShareholdersIn light of the significant difficulties in reaching the required quorum, the President of the Antibes Commercial Court, has appointed by order on May 6, 2025, SCP EZAVIN-THOMAS, represented in the person of Maître Nathalie Thomas, domiciled 1, Alexandre Mari – 06000 Nice, as ad hoc representative to represent defaulting shareholders at the Ordinary and Extraordinary Shareholder's Meeting convened for June 27, 2025 on first ad hoc representative will thus represent all the shares with voting rights held by shareholders who have not participated or are not represented at this General Meeting. The participation of the ad hoc representative will thus bring the quorum to 100% of shares with voting order to ensure the neutrality of the ad hoc representative's role, the voting rights attached to the shares of the defaulting shareholders will be exercised as follows: for ordinary resolutions, whether proposed, approved or not approved by the Board of Directors: half the votes in favor and half against; for extraordinary resolutions whether proposed or approved by the Board of Directors: two-thirds in favor and one-third against; for extraordinary resolutions not approved by the Board of Directors: one-third in favor and two-thirds against; Documentation and Participation in the General MeetingThe documents relating to the General Meeting, including the text of the draft resolutions and the proxy form, are made available to shareholders at the Company's headquarters and on its website ( may vote by proxy, by internet or by attending the Ordinary and Extraordinary Shareholder Meeting in person. A guide explaining how to vote, and notably how to vote by internet, is available on the Company's website. Shareholders may also contact the Company's Investor Relations team at ag2025nicox@ for any questions regarding the voting process. About Nicox Nicox SA is an international ophthalmology company developing innovative solutions to help maintain vision and improve ocular health. Nicox's lead program in clinical development is NCX 470 (bimatoprost grenod), a novel nitric oxide-donating bimatoprost eye drop, for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Nicox also has a preclinical research program on NCX 1728, a nitric oxide-donating phosphodiesterase-5 inhibitor, with Glaukos. Nicox's first product, VYZULTA® in glaucoma, licensed exclusively worldwide to Bausch + Lomb, is available commercially in the U.S. and over 15 other territories. Nicox generates revenue from ZERVIATE® in allergic conjunctivitis, licensed in multiple geographies, including to Harrow, Inc. in the U.S., and Ocumension Therapeutics in the Chinese and in the majority of Southeast Asian markets. Nicox, headquartered in Sophia Antipolis, France, is listed on Euronext Growth Paris (Ticker symbol: ALCOX) and is part of the CAC Healthcare index. For more information Analyst coverage H.C. Wainwright & Co Yi Chen New York, views expressed by analysts in their coverage of Nicox are those of the author and do not reflect the views of Nicox. Additionally, the information contained in their reports may not be correct or current. Nicox disavows any obligation to correct or to update the information contained in analyst reports. Contacts NicoxGavin SpencerChief Executive OfficerT +33 (0)4 97 24 53 00communications@ Disclaimer The information contained in this document may be modified without prior notice. This information includes forward-looking statements. Such forward-looking statements are not guarantees of future performance. These statements are based on current expectations or beliefs of the management of Nicox S.A. and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Nicox S.A. and its affiliates, directors, officers, employees, advisers or agents, do not undertake, nor do they have any obligation, to provide updates or to revise any forward-looking factors which are likely to have a material effect on Nicox's business are presented in section 3 of the 'Rapport Annuel 2024' which is available on Nicox's website ( this press release may be drafted in the French and English languages. If both versions are interpreted differently, the French language version shall prevail. Nicox Sophia Antipolis, Bâtiment C, Emerald Square, Rue Evariste Galois, 06410 Biot, FranceT +33 (0)4 97 24 53 00 Attachment EN_Nicox_CP_Annonce_AGOA_Mandataire_ad_hoc_FINALSign in to access your portfolio
